Screening for colorectal cancer and prostate cancer: Challenges for New Zealand

New Zealand Medical Journal

Volumn 127, Issue 1395, 2014, Pages 23-30

  Richardson, Ann K ^a   Potter, John D ^a,b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; ERECTILE DYSFUNCTION; FECES ANALYSIS; FECES INCONTINENCE; HUMAN; INVASIVE PROCEDURE; LIFE EXTENSION; LUNG EMBOLISM; MORBIDITY; MULTICENTER STUDY (TOPIC); NEW ZEALAND; OCCULT BLOOD TEST; PATIENT HARM; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGMOIDOSCOPY; SYSTEMATIC REVIEW (TOPIC); URGE INCONTINENCE; UROLOGIC SURGERY; VEIN THROMBOSIS; COLORECTAL TUMOR; COMPARATIVE EFFECTIVENESS; EARLY DIAGNOSIS; FEMALE; HEALTH CARE QUALITY; INCIDENCE; MALE; MASS SCREENING; METHODOLOGY; MORTALITY; PROSTATE TUMOR; REVIEW; RISK ASSESSMENT; STATISTICS; UNNECESSARY PROCEDURE;

COLORECTAL NEOPLASMS; COMPARATIVE EFFECTIVENESS RESEARCH; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MORTALITY; NEW ZEALAND; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STANDARD OF CARE; UNNECESSARY PROCEDURES;

EID: 84907184560     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ministry of Health. Cancer: new registrations and deaths 2010. Wellington: Ministry of Health; 2013.
2. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr (accessed on 8 April 2014).
3. Benson VS, Atkin WS, Green J, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network. Int J Cancer 2012;130:2961-73.
4. Moyer VAon behalf of the US Preventive Services Taskforce. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Int Med 2012;157:120-34.
5. UK National Screening Committee. The UK NSC policy on prostate cancer screening/PSA testing screening men over the age of 50. UK National Screening Committee 2010 http://www.screening.nhs.uk/prostatecancer (accessed on 8 April 2014)
6. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013;190:419-26.
7. Qaseem A, Barry MJ, Denberg TD, et al. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2013;158:761-9. doi: 10.7326/0003-4819-158-10-201305210-00633.
8. Early detection of prostate cancer: European Association of Urology recommendation. Eur Urol 2013;64:347-54.
9. Muir Gray JA. Evidence-based healthcare: how to make health policy and management decisions. New York: Churchill Livingstone, 1997.
10. Wilt TJ, Ahmed HU. Prostate cancer screening and the management of clinically localized disease. BMJ 2013;346:f325 doi: 10.1136/bmj.f325
11. Robinson MHE, Hardcastle JD, Moss SM, et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588-92.
12. Richardson A. Screening and the number needed to treat. J Med Screen 2001;8:125–127.
13. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998;317:559-65.
14. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:doi:10.1016/S0140-6736(10)60551-X
15. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
16. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecaloccult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
17. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. NEJM 2012;366:2345-57.
18. Djulbegivic M, Beyth RJ, Neuberger MN, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010;341:c4543 doi:10.1136/bmj.c4543
19. Boniol M, Boyle P, Autier P, Ruffion A, Perrin P. Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme. BJU International 2012;110:1648-53.
20. Bretthauer M, Kalager M. Principles, effectiveness and caveats in screening for cancer. Br J Surg 2013;100:55-65.
21. Ilic D, O’Connor D, Green S, Wilt TJ. Screening for prostate cancer: an updated Cochrane systematic review. BJU International 2011;107:882-91.
22. Glass A, Cooperberg MR, Meng M, Carroll PR. Role of active surveillance in the management of localized prostate cancer. JNCI 2012;45:202-6.
23. New Zealand Ministry of Health bowel screening pilot http://www.health.govt.nz/ourwork/diseases-and-conditions/cancer-programme/bowel-cancer-programme/bowel-screeningpilot (accessed on 8 April 2014).
24. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Int Med 2008;149:638-58.
25. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: Follow-up findings of the Italian randomized controlled trial - SCORE. J Natl Cancer Inst 2011;103:1310–22.
26. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial: Added yield from a second screening examination. J Natl Cancer Inst 2012;104:280–9.
27. Green T, Richardson A, Parry S. Colonoscopy requirements of population screening for colorectal cancer in New Zealand. N Z Med J 2012;125(1356). http://journal.nzma.org.nz/journal/125-1356/5220/
28. Public Health England. NHS bowel cancer screening programme: NHS bowel scope screening http://www.cancerscreening.nhs.uk/bowel/bowel-scope-screening.html (accessed on 8 April 2014).
29. Altobelli E, Lattanzi A, Paduano R, et al. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med 2014;62:132-41.
30. Cox B, Sneyd MJ. Prospects for cancer control: colorectal cancer. N Z Med J 2005;118(1221). http://journal.nzma.org.nz/journal/118-1221/1632/
31. Cox B, Sneyd MJ. Bowel cancer screening in New Zealand. N Z Med J 2013;126(1385). http://journal.nzma.org.nz/journal/126-1385/5888/